Substrates with biocidal coating

ABSTRACT

The present invention provides a process for coating the surface of a substrate comprises the following steps (i) oxidizing the surface of the substrate (ii) applying a composition comprising one or more quaternary ammonium compounds carrying one or more ethylenically unsaturated groups onto the oxidized surface of the substrate and (iii) curing the composition in order to form a coating layer, and substrates obtainable by the latter process.

The present invention refers to a process for coating the surface of asubstrate with a biocidal coating layer and to substrates with biocidalsurfaces obtainable by the latter process.

Substrates can be treated with biocides in order to protect thesubstrate from biological infestation and growth. The undesirableaccumulation of biological materials such as plants, algae ormicroorganisms on the surface of the subrate is usually referred to asbiological fouling. Common antifouling agents are tetrabutyl tin (TBT)or phenyl mercuric acetate. The antifouling agents leak into theenvironment and thus contaminate the environment. The leakage of thesebiocides can cause resistancies among the target organisms, and as theantifouling agents are usually also highly toxic to not target organismssuch as human beings and other mammals, undesired harm to theseorganisms can not be excluded.

Therefore, several attempts have been made in the past to developbiocidal coatings, where the biocidal agent is covalently attached tothe surface of the substrate and thus does not leak into theenvironment.

DE 102 11 562 A1 describes substrates with an antimicrobial surface,which are prepared by treatment of the surface of the substrate with anantimicrobial polymer or copolymer having at least one quaternaryammonium group and at least one group capable of forming a covalent bondto the substrate, which group is preferably a primary or secondary aminogroup.

US 2006/0008490 A1 and WO 2005/084159 describe substrates with abiocidal surface, which are prepared by immobilization of the substratewith an initiator, polymerizing monomers carrying groups capable ofbeing converted to biocidal active groups onto the immobilized initiatorand, after polymerization, converting these groups into biocidal activegroups.

The disadvantage of the biocidal coatings described in DE 102 11 562 A1,US 2006/0008490 A1 and WO 2005/084159 is that it is not possible toeasily prepare those biocidal coatings on existing printing equipment ina large volume continuous process.

Thus, it is the object of the present invention to provide a process forcoating a substrate with a biocidal coating layer, which process istechnically feasible in large volumes and in a continuous mode onexisting printing equipment and which process produces biocidalcoatings, where no biocides leak into the environment. In addition, itis desirable that the biocidal layer shows a high durability, whichmeans that the biocidal activity of the biocidal coating layer is notsignificantly affected upon exposure of the biocidal layer to variousenvironmental conditions, for example upon prolonged exposure of thebiocidal layer to water.

This object is solved by the process of claim 1, the substrate of claim10 and the mixture of claim 11.

The process of the present invention for coating the surface of asubstrate comprises the following steps

(i) oxidizing the surface of the substrate(ii) applying a composition comprising one or more quaternary ammoniumcompounds carrying one or more ethylenically unsaturated groups onto theoxidized surface of the substrate and(iii) curing the composition in order to form a coating layer.

The substrate can be a two-dimensional object such as a sheet or a film,or any three dimensional object; it can be transparent or opaque. Thesubstrate can be made from paper, cardboard, wood, leather, metal,textiles, glass, ceramics, stone and/or polymers.

Examples of metals are iron, nickel, palladium platin, copper, silver,gold, zinc and aluminium and alloys such as steel, brass, bronze andduralumin.

Textiles can be made from natural fibres such as fibres from animal orplant origin, or from synthetic fibres. Examples of natural fibres fromanimal origin are wool and silk. Examples of natural fibres from plantorigin are cotton, flax and jute. Examples of synthetic textiles arepolyester, polyacrylamide, polyolefins such as polyethylene andpolypropylene and polyamides such as nylon and lycra.

Examples of ceramics are products made primarily from clay, for examplebricks, tiles and porcelain, as well as technical ceramics. Technicalceramics can be oxides such as aluminium oxide, zirconium dioxide,titanium oxide and barium titanate, carbides such as sodium, silicon orboron carbide, borides such as titanium boride, nitrides such astitanium or boron nitride and silicides such as sodium or titaniumsilicide.

Examples of stones are limestone, granite, gneiss, marble, slate andsandstone.

Examples of polymers are acrylic polymers, styrene polymers andhydrogenated products thereof, vinyl polymers and derivatives thereof,polyolefins and hydrogenated or epoxidized products thereof, aldehydepolymers, epoxide polymers, polyamides, polyesters, polyurethanes,polycarbonates, sulfone-based polymers and natural polymers andderivatives thereof.

Acrylic polymers can be polymers formed from at least one acrylicmonomer or from at least one acrylic monomer and at least one otherethylenically unsaturated monomer such as a styrene monomer, vinylmonomer, olefin monomer or maleic monomer.

Examples of acrylic monomers are (meth)acrylic acid, (meth)acrylamide,(meth)acrylonitrile, ethyl (meth)acrylate, butyl (meth)acrylate, hexyl(meth)acrylate, 2-ethylhexyl (meth)acrylate, glycidyl methacrylate,acetoacetoxyethyl methacrylate, dimethylaminoethyl acrylate anddiethylaminoethyl acrylate. Examples of styrene monomers are styrene,4-methylstyrene and 4-vinylbiphenyl. Examples of vinyl monomers arevinyl alcohol, vinyl chloride, vinylidene chloride, vinyl isobutyl etherand vinyl acetate. Examples of olefin monomers are ethylene, propylene,butadiene and isoprene and chlorinated or fluorinated derivativesthereof such as tetrafluoroethylene. Examples of maleic monomers aremaleic acid, maleic anhydride and maleimide.

Examples of acrylic polymers are poly(methyl methacrylate) (PMMA),poly(butyl methacrylate), polyacrylonitrile (PAN), polyacrylic acid,styrene/2-ethylhexyl acrylate copolymer, styrene/acrylic acid copolymer.

Styrene polymers can be polymers formed from at least one styrenemonomer or from at least one styrene monomer and at least one vinylmonomer, olefin monomer and/or maleic monomer. Examples of styrenepolymers are polystyrene (PS), styrene butadiene styrene block polymers,styrene ethylene butadiene block polymers, styrene ethylene propylenestyrene block polymers and styrene-maleic anhydride copolymers.

Vinyl polymers can be polymers formed from at least one vinyl monomer orfrom at least one vinyl monomer and at least one olefin monomer ormaleic monomer. Examples of vinyl polymers are polyvinyl chloride (PVC),polyvinylidenfluoride (PVDF), polyvinylalcohol, polyvinylacetate,partially hydrolysed polyvinyl acetate and methyl vinyl ether-maleicanhydride copolymers. Examples of derivatives thereof arecarboxy-modified polyvinyl alcohol, acetoacetyl-modified polyvinylalcohol, diacetone-modified polyvinyl alcohol and silicon-modifiedpolyvinyl alcohol.

Polyolefins can be polymers formed from at least one olefin monomer orfrom at least one olefin monomer and maleic monomer. Examples ofpolyolefines are low-density polyethylene (LOPE), high-densitypolyethylene (HDPE), polypropylene (PP), biaxially orientatedpolypropylene (BOPP), polybutadiene, polytetrafluoroethylene(Teflon-PTFE), chlorinated polyethylene and isopropylene-maleicanhydride copolymer.

Aldehyde polymers can be polymers formed from at least one aldehydemonomer or polymer and at least one alcohol monomer or polymer, aminemonomer or polymer and/or urea monomer or polymer. Examples of aldehydemonomers are formaldehyde, furfural and butyral. Examples of alcoholmonomers are phenol, cresol, resorcinol and xylenol. An example of apolyalcohol is polyvinyl alcohol. Examples of amine monomers are anilineand melamine. Examples of urea monomers are urea, thiurea anddicyandiamide. An example of an aldehyde polymer is polyvinyl butyralformed from butyral and polyvinylalcohol.

Epoxide polymers can be polymers formed from at least one epoxidemonomer and at least one alcohol monomer and/or amine monomer. Examplesof epoxide monomers are epichlorohydrine and glycidol. Examples ofalcohol monomers are phenol, cresol, resorcinol, xylenol, bisphenol Aand glycol. An example of epoxide polymer is phenoxy resin, which isformed from epichlorihydrin and bisphenol A.

Polyamides can be polymers formed from at least one monomer having anamide group or an amino as well as a carboxy group or from at least onemonomer having two amino groups and at least one monomer having twocarboxy groups. An example of a monomer having an amide group iscaprolactam. An example of a diamine is 1,6-diaminohexane. Examples ofdicarboxylic acids are adipic acid, terephthalic acid, isophthalic acidand 1,4-naphthalene-dicarboxylic acid. Examples of polyamides arepolyhexamethylene adipamide and polycaprolactam.

Polyesters can be polymers formed from at least one monomer having ahydroxy as well as a carboxy group or from at least one monomer havingtwo hydroxy groups and at least one monomer having two carboxy groups ora lactone group. An example of a monomer having a hydroxy as well as acarboxy group is adipic acid. An example of a diol is ethylene glycol.An example of a monomer having a lactone group is carprolactone.Examples of dicarboxylic acids are terephthalic acid, isophthalic acidand 1,4-naphthalenedicarboxylic acid. An example of a polyester ispolyethylene terephthalate (PET). So-called alkyd resins are alsoregarded to belong to polyester polymers.

Polyurethane can be polymers formed from at least one diisocyanatemonomer and at least one polyol monomer and/or polyamine monomer.Examples of diisocyanate monomers are hexamethylene diisocyanate,toluene diisiocyanate, isophorone diisocyanate and diphenylmethanediisocyanate.

Examples of polycarbonates are poly(aromatic carbonates) andpoly(aliphatic carbonates). Poly(aliphatic carbonates) can be formedfrom carbon dioxide and at least one epoxide.

Examples of sulfone-based polymers are polyarylsulfone, polyethersulfone(PES), poly-phenylsulfone (PPS) and polysulfone (PSF). Polysulfone (PSF)is a polymer formed from 4,4-dichlorodiphenyl sulfone and bisphenol A.

Examples of natural polymers are starch, cellulose, gelatine, caesin andnatural rubber. Examples of derivatives are oxidised starch,starch-vinyl acetate graft copolymers, hydroxyethyl cellulose,hydroxypropyl cellulose, methyl cellulose, nitryl cellulose, ethylcellulose, carboxymethyl cellulose and acetyl cellulose.

The substrate can be a substrate used in the medicinal field such aswound care bandages, catheters, implants, artificial organs, artificialjoints, artificial blood vessels and medicinal devices such asstethoscopes, tubes, syringes and needles.

The substrate can be a water liner or packaging, for example foodpackaging. The substrate could also be a membrane.

The substrate can contain biocides.

Preferably, the substrate is made from polymer. More preferably, thesubstrate is made from polymer selected from the group consisting ofstyrene polymers, vinyl polymers and derivatives thereof, polyolefins,polyesters and sulfone-based polymers. Even more preferably, thesubstrate is made from polyolefins. Most preferably, the substrate ismade from polypropylene (PP) or a biaxially orientated polypropylene(BOPP).

Preferably, the substrate made from polymer is a film.

The oxidation of the surface of the substrate can be performed, forexample, by treatment with corona discharge, plasma, flame, ozone,electron-beam, X-ray or ultraviolet radiation.

Corona discharges can be electrical discharges characterized by a coronaand occurring when one of two electrodes in a gas has a shape causingthe electric field at its surface to be significantly greater than thatbetween the electrodes. Air is usually used as gas. The substrate isusually located at ambient pressure in the discharge field between thetwo electrodes, for example by passing a film as substrate between twoelectrodes.

Plasma can be a gas where electrons and ions are present. Plasma can begenerated by the treatment of gases with high temperatures or highelectric fields. Plasma treatment is usually carried out in vacuumchambers at 10 to 100 Pa with a nonthermal plasma in a gas atmosphereconsisting of an inert gas or reactive gas, for example oxygen.

Flame can be flames that are formed when a flammable gas and an oxygencontaining gas, for example atmospheric air, are combined and combusted.Examples of flammable gases are propane, butane or town gas. Flametreatment is usually carried out at ambient pressure.

Ozone can be generated from atmospheric oxygen in a corona discharge orby ultraviolet radiation.

Electron beam can be generated by electron beam accelerators, forexample by cathode ray tubes.

X-rays can be generated by X-ray generators, for example by X-ray-tubes.

Preferably, the oxidation of the surface is performed by treatment withcorona discharge, plasma or flame. More preferably, it is performed bycorona discharge treatment.

Any quaternary ammonium compound carrying one or more ethylenicallyunsaturated groups, which is capable of polymerization, can be used.Preferably, the one or more quaternary ammonium compounds carrying oneor more ethylenically unsaturated groups are of formula

whereinR¹, R² and R³ can be the same or different and are hydrogen, halogen orC₁₋₆-alkyl, R⁴, R⁵ and R⁶ can be the same or different and areC₁₋₃₀-alkyl, C₂₋₃₀-alkenyl, C₃₋₈-cycloalkyl, aryl, or R⁴ and R⁵ togetherwith the N of the ammonium group form a 4 to 8 membered cycle,wherein one CH₂ group of the cycle may be replaced with NH or O,Q and Y can be the same or different and are C₁₋₁₅-alkylene,M is a bridging group,n and m can be the same or different and are 0 or 1,J′ is an anion,wherein C₁₋₃₀-alkyl, C₂₋₃₀-alkenyl, C₃₋₈-cycloalkyl or C₁₋₁₅-alkylenecan be unsubstituted or substituted with one or more aryl,OC₂₋₆-alkenyl, halogen, CN, C(O)OR⁷, C(O)NR⁸R⁹, OR¹⁰, NR¹¹R¹²,NHC(O)C(R¹³)═C(R¹⁴)R¹⁵, OC(O)C(R¹⁶)═C(R¹⁷)R¹⁸ or C(O)OC(R¹⁹)═C(R²⁰)R²¹;wherein aryl can be unsubstituted or substituted with one or moreC₁₋₆-alkyl, C₂₋₆-alkenyl, OC₂₋₆-alkenyl, halogen, CN, C(O)OR⁷,C(O)NR⁸R⁹, OR¹⁰, NR¹¹R¹², NHC(O)C(R¹³)═C(R¹⁴)R¹⁵, OC(O)C(R¹⁶)═C(R¹⁷)R¹⁸or C(O)OC(R¹⁹)═C(R²⁰)R²¹;wherein R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, R¹⁶, R¹⁷, R¹⁸, R¹⁹,R²⁰ and R²¹ can be the same or different and are hydrogen or C₁₋₆-alkyl,and one or more CH₂-groups of C₁₋₁₅-alkylene can be replaced byN—CH₂—CH═CH₂, CH—CH═CH₂, NH and/or O.

C₁₋₆-Alkyl can be branched or unbranched and can be methyl, ethyl,propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl orhexyl.

C₁₋₃₀-Alkyl can be branched or unbranched. Examples of C₁₋₃₀-alkyl aremethyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl,tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl,dodecyl, tetradecyl, pentadecyl, hexadecyl, octadecyl, eicosyl,heneicosyl, docosyl, tetracosyl and triacontyl.

Examples C₃₋₈-cycloalkyl are cyclopropyl, cyclobutyl, cyclopentyl,cyclohexyl, cycloheptyl and cyclooctyl.

Examples of C₂₋₃₀-alkenyl and C₁₋₆-alkenyl are vinyl and allyl.

Aryl can be phenyl or naphthyl or heteroaryl such as imidazyl, pyrryl orisocyanuryl. Preferably, aryl is phenyl.

Examples of C₁₋₁₅-alkylene are methylene, propylene and butylene.

Examples of bridging groups M are C₃₋₈-cycloalkylene, arylene, polymer,OC(O), C(O)O, NH(CO) and C(O)NH. Arylene can be phenylene. An example ofa polymer is polyethyleneimine.

J′ can be any anion, for example sulfate, sulfite, carbonate, phosphateor halogenide. Halogenide can be fluoridne, chloride, bromide or iodide.

Examples of quaternary ammonium compounds carrying one or moreethylenically unsaturated group are trimethylaminoethyl acrylatechloride, trimethylaminoethyl methacrylate chloride,trimethylaminotetradecyl acrylate chloride, trimethylaminohexadecylacrylate chloride, trimethylaminooctadecyl acrylate chloride anddiallyldimethylammonium chloride and the compounds of formulae

More preferred quaternary ammonium compounds carrying one or moreethylenically unsaturated group are of formula

whereinR¹, R² and R³ can be the same or different and are hydrogen orC₁₋₆-alkyl,R⁴, R⁵ and R⁶ can be the same or different and are C₁₋₃₀-alkyl orC₂₋₃₀-alkenyl,Q and Y can be the same or different and are C₁₋₁₅-alkylene,M is a bridging group selected from the group consisting of arylene,polymer, OC(O) and C(O)O,n and m can be the same or different and are 0 or 1,J′ is a halogenide,wherein C₁₋₃₀-alkyl, C₂₋₃₀-alkenyl or C₁₋₁₅-alkylene can beunsubstituted or substituted with one or more OC₂₋₆-alkenyl, C(O)OR⁷,C(O)NR⁸R⁹, OR¹⁰, NR¹¹R¹², NHC(O)C(R¹³)═C(R¹⁴)R¹⁵, OC(O)C(R¹⁶)═C(R¹⁷)R¹⁸or C(O)OC(R¹⁹)═C(R²⁰)R²¹;wherein R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, R¹⁶, R¹⁷, R¹⁸, R¹⁹,R²⁰ and R²¹ can be the same or different and are hydrogen or C₁₋₆-alkyl,and one or more CH₂-groups of C₁₋₁₅-alkylene can be replaced byN—CH₂—CH═CH₂, CH—CH═CH₂, NH and/or O.

Most preferred quaternary ammonium compounds carrying one or moreethylenically unsaturated groups are of formula

whereinR¹, R² and R³ can be the same or different and are hydrogen orC₁₋₆-alkyl,R⁴, R⁵ and R⁶ can be the same or different and are C₁₋₃₀-alkyl,Q and Y can be the same or different and are C₁₋₆-alkylene,M is a bridging group selected from the group consisting of polymer andOC(O),n and m can be the same or different and are 0 or 1,J′ is a halogenide,wherein C₁₋₃₀-alkyl or C₁₋₆-alkylene can be unsubstituted or substitutedwith one or more OR¹⁰, wherein R¹⁰ can be hydrogen or C₁₋₆-alkyl,and one or more CH₂-groups of C₁₋₆-alkylene can be replaced byN—CH₂—CH═CH₂.

Examples of C₁₋₆-alkylene are methylene, propylene and butylene.

Compound 1A is an especially preferred quaternary ammonium compoundcarrying one or more ethylenically unsaturated groups.

Compounds of formula 1 can be prepared, for example, by reacting anamine of formula

with a compound of formula

J-R⁴  (3)

For example, compound 1A can be prepared by reactingN,N-dimethylaminoethyl methacrylate with dodecyl bromide as described inS. M. Hamid and D. C. Sherrington, Polymer 1987, 28, 325 to 331.

The composition comprising one or more quaternary ammonium compoundscarrying one or more ethylenically unsaturated groups can also compriseone or more further ethylenically unsaturated compounds, which can beany ethylenically unsaturated compounds capable of polymerization.

The further ethylenically unsaturated compound can be a macromonomercapable of forming a polymer having at least five macromonomer units,which macromonomer has a molecular weight ranging from 1,000 to1,000,000,000 g/mol and carries ethylenically unsaturated groups.Preferred macromonomers are those wherein the ethylenically unsaturatedgroups are (meth)acryloyl moieties. Examples of macromonomers of thiskind are (meth)acryloyl-modified polyesters, (meth)acryloyl-modifiedpolyvinyl alcohol, (meth)acryloyl-modified partially hydrolysedpolyvinyl acetate, (meth)acryloyl-modified methyl vinyl ether-maleicanhydride copolymer, (meth)acryloyl-modified methyl isopropylene-maleicanhydride copolymer, (meth)acryloyl-modified polyurethane and(meth)acryloyl-modified cellulose.

Particular preferred macromonomers are those which carry at least twoethylenically unsaturated groups, which are (meth)acryloyl moieties.

An example of a macromonomer carrying at least two acryloyl moieties isSartomer CN2301 sold by Sartomer company, which is a branched polyesteracrylate oligomer containing multiple acrylate functionalities.

The further ethylenically unsaturated compound can also be of formula

whereinR²², R²³ and R²⁴ can the same or different and can be hydrogen, halogenor C₁₋₆-alkyl,A can be aryl, halogen, CN, C(O)R²⁵, C(O)OR²⁶, OR²⁷, OC(O)R²⁸,NR²⁹C(O)R³⁰ or C(O)NR³¹R³², wherein aryl can be unsubstituted orsubstituted as outlined below,whereinR²⁵, R²⁶, R²⁷, R²⁸, R³¹ and R³² can be the same or different and can behydrogen, C₁₋₁₀₀-alkyl, C₃₋₈-cycloalkyl, C₂₋₃₀-alkenyl, aryl,C₁₋₆-alkylene-aryl-C₁₋₆-alkyl, C₁₋₆-alkylene-aryl-(C₁₋₆-alkyl)₂,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-C₁₋₆-alkyl,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-(C₁₋₆-alkyl)₂ oraryl-C₁₋₃₀-alkylene-aryl, and R²⁹ and R³⁰ can be the same or differentand can have the same meaning as R²⁶, and in addition, together withNC(O) can form a four to seven membered cycle, whereinC₁₋₁₀₀-alkyl, C₁₋₆-alkylene-aryl-C₁₋₆-alkyl,C₁₋₆-alkylene-aryl-(C₁₋₆-alkyl)₂,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-C₁₋₆-alkyl andC₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-(C₁₋₆-alkyl)₂ can be unsubstituted orsubstituted with one or more C₃₋₈-cycloalkyl, aryl, OC₂₋₃₀-alkenyl,halogen, CN, C(O)OR³³, C(O)NR³⁴R³⁵, OR³⁶, NR³⁷R³⁸,NHC(O)C(R³⁹)═C(R⁴⁰)R⁴¹, OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ or C(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷;C₂₋₃₀-alkenyl group can be unsubstituted or substituted with one or moreC₃₋₈-cycloalkyl, aryl, halogen, CN, C(O)OR³³, C(O)NR³⁴R³⁵, OR³⁶,NR³⁷R³⁸, NHC(O)C(R³⁸)═C(R⁴⁰)R⁴¹, OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ orC(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷,aryl or aryl-C₁₋₃₀-alkylene-aryl group can be unsubstituted orsubstituted with one or more C₁₋₆-alkyl, C₃₋₈-cycloalkyl, C₂₋₃₀-alkenyl,halogen, CN, C(O)OR³³, C(O)NR³⁴R³⁵, OR³⁶, NR³⁷R³⁸,NHC(O)C(R³⁹)═C(R⁴⁰)R⁴¹, OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ or C(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷,whereinR³³, R³⁴, R³⁵, R³⁶, R³⁷, R³⁸, R³⁹, R⁴⁰, R⁴¹, R⁴², R⁴³, R⁴⁴, R⁴⁵, R⁴⁶ andR⁴⁷ can be the same or different and can be hydrogen or C₁₋₆-alkyl, andwhereinone or more CH₂-groups of C₁₋₁₀₀-alkyl or C₂₋₃₀-alkenyl can be replacedwith —O—, —NH— and/or phenylene, and one CH₂-group of C₃₋₈-cycloalkylcan be replaced with —O—.

C₁₋₁₀₀-alkyl can be branched or unbranched. Examples of C₁₋₁₀₀-alkyl aremethyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl,tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyltetradecyl, pentadecyl, hexadecyl, octadecyl, icosyl, eicosyl, docosyl,tetracosyl and triacontyl.

An example of C₁₋₆-alkylene-aryl-(C₁₋₆-alkyl)₂ is triethyl isocyanurate.An example of C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-C₁₋₆-alkyl is dimethyltricyclodecane.

Examples of aryl-C₁₋₃₀-alkylene-aryl are phenyl-ethylene-phenyl andphenyl-propylene-phenyl.

Examples of ethylenically unsaturated compounds of formula 4 are methylacrylate, ethyl acrylate, butyl acrylate, 2-ethylhexyl acrylate,2-hydroxyethyl acrylate, glycidyl methacrylate, methyl methacrylate,ethyl methacrylate, acrylonitrile, acrylamide, methacrylic acid,methacrylamide, vinyl acetate, isobutyl vinyl ether, styrene,N-vinylpyrrolidinone, vinyl chloride, vinylidene chloride, ethyleneglycol diacrylate, hexamethylene glycol diacrylate, propylene glycoldiacrylate, dipropylene glycol diacrylate, tripropylene glycoldiacrylate, neopentyl glycol diacrylate, bisphenol A diacrylate,tricyclodecane dimethanol diacrylate,4,4′-bis(2-acryloyloxyethoxy)diphenylpropane, vinyl acrylate, vinylmethacrylate, divinylbenzene, divinyl succinate,ethyleneglycoldivinylether, diethyleneglycoldivinylether,triethyleneglycoldivinylether, glycerol ethoxylate triacrylate, glycerolpropoxylate triacrylate, trimethylolpropaneethoxylate triacrylate,trimethyolpropanepropoxylate triacrylate, 2-hydroxy-ethyl isocyanuratetriacrylate, pentaerythritol ethoxylate tetraacrylate, pentaerythritolpropoxylate triacrylate, pentaerythritol propoxylate tetraacrylate,trimethylolpropane triacrylate, ethoxylated (6) trimethylolpropanetriacrylate, ethoxylated (9) trimethylolpropane triacrylate, ethoxylated(15) trimethylolpropane triacrylate, pentaerythritol triacrylate,pentaerythritol tetraacrylate, dipentaerythritol pentaacrylate,neopentyl glycol ethoxylate diacrylate and neopentyl glycol propoxylatediacrylate, polyethylene glycol (400) diacrylate, polyethylene glycol(400) dimethacrylate, polyethylene glycol (600) diacrylate, polyethyleneglycol (600) dimethacrylate and polyethyleneglycol-mono-methacrylate.

Preferably, R²², R²³ and R²⁴ are the same or different and are hydrogenor C₁₋₆-alkyl.

Preferably, A is C(O)OR²⁶ or C(O)NR³¹R³², wherein R²⁶, R³¹ and R³² canbe the same or different and are hydrogen, C₁₋₁₀₀-alkyl, C₂₋₃₀-alkenyl,C₁₋₆-alkylene-aryl-(C₁₋₆-alkyl)₂,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-C₁₋₆-alkyl or aryl-C₁₋₃₀-alkylene-aryl;wherein C₁₋₁₀₀-alkyl, C₁₋₆-alkylene-aryl-(C₁₋₆-alkyl)₂ andC₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-C₁₋₆-alkyl are substituted with one ormore OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ or NHC(O)C(R³⁹)═C(R⁴⁰)R⁴¹, and mayadditionally be substituted with one or more C₃₋₈-cycloalkyl,O—C₂₋₃₀-alkenyl, OR³⁶, NR³⁷R³⁸ or C(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷, and aryl issubstituted with one or more C(O)C(R⁴²)═C(R⁴³)R⁴⁴; R³⁶, R³⁷, R³⁸, R³⁹,R⁴⁰, R⁴¹, R⁴², R⁴³, R⁴⁴, R⁴⁵, R⁴⁶ and R⁴⁷ can be the same or differentand are hydrogen or C₁₋₆-alkyl, and one or more CH₂-groups ofC₁₋₁₀₀-alkyl or C₂₋₃₀-alkenyl can be replaced with —O—, —NH— and/orphenylene, and one CH₂-group of C₃₋₈-cycloalkyl can be replaced with—O—.

More preferably, A is C(O)OR²⁶, wherein R²⁶ is C₁₋₁₀₀-alkyl, whereinC₁₋₁₀₀-alkyl is substituted with one or more OC(O)C(R⁴²)═C(R⁴³)R⁴⁴; R⁴²,R⁴³ and R⁴⁴ can be the same or different and are hydrogen or C₁₋₆-alkyl,and one or more CH₂-groups of C₁₋₁₀₀-alkyl can be replaced with —O—,—NH— and/or phenylene.

Most preferably, A is C(O)OR²⁶, wherein R²⁶ is C₁₋₁₀₀-alkyl, whereinC₁₋₁₀₀-alkyl is substituted with one or more OC(O)C(R⁴²)═C(R⁴³)R⁴⁴; R⁴²,R⁴³ and R⁴⁴ can be the same or different and are hydrogen or C₁₋₆-alkyl,and one or more CH₂-groups of C₁₋₁₀₀-alkyl can be replaced with —O—.

Examples of most preferred ethylenically unsaturated compound of formula4 are ethylene glycol diacrylate, hexamethylene glycol diacrylate,propylene glycol diacrylate, dipropylene glycol diacrylate, tripropyleneglycol diacrylate, neopentyl glycol diacrylate, glycerol ethoxylatetriacrylate, glycerol propoxylate triacrylate,trimethylolpropaneethoxylate triacrylate, trimethyolpropanepropoxylatetriacrylate, pentaerythritol ethoxylate tetraacrylate, pentaerythritolpropoxylate triacrylate, pentaerythritol propoxylate tetraacrylate,trimethylolpropane triacrylate, ethoxylated (6) trimethylolpropanetriacrylate, ethoxylated (9) trimethylolpropane triacrylate, ethoxylated(15) trimethylolpropane triacrylate, pentaerythritol triacrylate,pentaerythritol tetraacrylate, dipentaerythritol pentaacrylate,neopentyl glycol ethoxylate diacrylate, neopentyl glycol propoxylatediacrylate, polyethylene glycol (400) diacrylate, polyethylene glycol(400) dimethacrylate, polyethylene glycol (600) diacrylate andpolyethylene glycol (600) dimethacrylate.

The compounds listed above are commercially available. For example,polyethylene glycol (600) diacrylate and polyethylene glycol (600)dimethacrylate are available from Sartomer Company. Alternatively, thesecompounds can be prepared by reacting the corresponding alcohol withmethyl acrylate, respectively, methyl methacrylate. For example,polyethylene glycol (600) diacrylate and polyethylene glycol (600)dimethacrylate can be prepared by reacting polyethylene glycol (600)with methyl acrylate, respectively, methyl methacrylate.

The further ethylenically unsaturated compound can also be an allylradical, for example diallylphthalate, triallylphosphate andtriallylisocyanurate.

The composition comprising one or more quaternary ammonium compoundscarrying one or more ethylenically unsaturated groups can also compriseone or more radical initiator.

The one or more radical initiators can be thermal initiators such as2,2-azobisisobutyronitrile or photoinitiators. Preferably, the one ormore radical initiators are photoinitiators.

The photoinitiator can be of formula

whereinL can be hydrogen or

wherein C₁₋₆-alkylene can be unsubstituted or substituted with hydroxyl,andR⁴⁸, R⁴⁹ and R⁵⁰ can be the same or different and can be hydrogen,halogen, hydroxyl, C₁₋₆-alkyl, aryl, O—C₁₋₆-alkyl, O-aryl, S—C₁₋₆-alkyl,S-aryl or NR⁵¹R⁵², wherein R⁵¹ and R⁵² can be the same or different andcan be hydrogen or C₁₋₆-alkyl, or together with the nitrogen form a fiveto seven membered cycle, wherein a CH₂ group of the cycle can bereplaced with —O—, and C₁₋₆-alkyl, O—C₁₋₆-alkyl and S—C₁₋₆-alkyl can beunsubstituted or substituted with one or more hydroxyl, C₂₋₃₀-alkenyl,OC(O)C₂₋₃₀-alkenyl or aryl, and

X can be

wherein E and G can be —O—, —S— or NR⁶¹, wherein R⁶¹ can be hydrogen orC₁₋₆-alkyl, or R⁶¹ and R⁵³, respectively, R⁵⁶ can, together with thenitrogen, form a five to seven membered cycle, wherein a CH₂ group ofthe cycle can be replaced with —O—, NH, NC(O)C(R⁶²)C═C(R⁶³)R⁶⁴ and/or

R⁵³, R⁵⁶ and R⁶⁰ can be the same or different and can be hydrogen,C₁₋₁₀₀-alkyl, C₃₋₈-cyclo-alkyl, C₂₋₃₀-alkenyl, aryl or C(O)R⁶⁵;R⁵⁷, R⁵⁸ and R⁵⁹ can be the same or different and can be hydrogen,C₁₋₁₀₀-alkyl, O—C₁₋₁₀₀-alkyl, S—C₁₋₁₀₀-alkyl, NR⁶⁶C₁₋₁₀₀-alkyl,C₃₋₈-cycloalkyl, C₂₋₃₀-alkenyl, aryl or C(O)R⁶⁵, wherein R⁶⁶ can havethe same meaning as R⁵³ and R⁶⁵ can have the same meaning as R⁵⁷;R⁵⁴ and R⁵⁵ can have the same meaning as R⁵⁷ and in addition can,together with the linking carbon atom, form a five to seven memberedcycle,C₁₋₁₀₀-alkyl and C₂₋₃₀-alkenyl can be unsubstituted or substituted withone or more C₃₋₈-cycloalkyl, aryl, halogen, amino, hydroxyl, CN, COOH,C(O)R⁶⁷, C(O)OR⁶⁸, C(O)NR⁶⁹R⁷⁰, OR⁷¹, OC(O)R⁷², OC(O)C(R⁷³)═C(R⁷⁴)R⁷⁵,C(O)OC(R⁷⁶)═C(R⁷⁷)R⁷⁸,

wherein R⁶², R⁶³, R⁶⁴, R⁶⁷, R⁶⁸, R⁶⁹, R⁷⁰, R⁷¹, R⁷², R⁷³, R⁷⁴, R⁷⁵, R⁷⁶,R⁷⁷ and R⁷⁸ can be the same or different and can be hydrogen orC₁₋₆-alkyl,aryl can be unsubstituted or substituted with one or more C₁₋₄-alkyl,C₃₋₈-cycloalkyl, C₂₋₃₀-alkenyl, halogen, hydroxyl, CN, COOH, C(O)R⁶⁷,C(O)OR⁶⁸, C(O)NR⁶⁹R⁷⁰, OR⁷¹, OC(O)R⁷², OC(O)C(R⁷³)═C(R⁷⁴)R⁷⁵ orC(O)OC(R⁷⁶)═C(R⁷⁷)R⁷⁸; andone or more CH₂-groups of C₁₋₁₀₀-alkyl or C₂₋₃₀-alkenyl can be replacedwith —O—, —NR⁶¹— and/or phenylene, and one CH₂-group of C₃₋₈-cycloalkylcan be replaced with —O—.

Examples of C₁₋₆-alkylene are methylene, propylene and butylene.

C₁₋₁₀₀-alkyl can be branched or unbranched. Examples of C₁₋₁₀₀-alkyl aremethyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl,tert-butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl,dodecyl, tetradecyl, pentadecyl, hexadecyl, octadecyl, eicosyl,heneicosyl, docosyl, tetracosyl and triacontyl.

Examples of photoinitiators of formula 5 are benzoin ethers such asbenzoin ethyl ether, benzyl monoketals such as2,2-diethoxy-1-phenylethanon and 2,2-diethoxy-1,2-diphenyl-ethanon,alpha-substituted acetophenone derivatives such as2-hydroxy-2-methyl-1-phenylpropan-1-one (sold by Ciba SpecialtyChemicals under the tradename Ciba® Darocure® 1173), 1-hydroxycyclohexylphenyl ketone, 2-methyl-4′-(methylthio)-2-morpholino-propiophenone and2-benzyl-2-(dimethylamino)-4′-morpholinobutyrophenone, acylphosphineoxides such as diphenyl(2,4,6-trimethylbenzoyl)-phosphine oxide (sold byBASF under the tradename Lucirin® TPO) orphenylbis(2,4,6-trimethylbenzoyl)-phosphine oxide (sold by CibaSpecialty Chemicals under the tradename Ciba® Irgacure 819),alpha-acyloximester such as1-[4-(phenylthio)phenyl]-2-(O-benzoyloxim)octan-1,2-dione, andphenylglyoxalic acid esters such as diethyleneglycoldi(phenylglyoxylate), triethyleneglycol di(phenylglyoxylate),polyethylene glycol (150) di(phenylglyoxylate), polyethylene glycol(300) di(phenylglyoxylate), polyethylene glycol (400)di(phenylglyoxylate) and polyethylene glycol (600) di(phenylglyoxylate).

In preferred compounds of formula 5, R⁴⁸, R⁴⁹ and R⁵⁰ can be the same ordifferent and are hydrogen, hydroxyl, C₁₋₆-alkyl, O—C₁₋₆-alkyl,S—C₁₋₆-alkyl, S-aryl or NR⁵¹R⁵², wherein R⁵¹ and R⁵² can be the same ordifferent and can be hydrogen or C₁₋₆-alkyl, or together with thenitrogen form a five to seven membered cycle, wherein a CH₂ group of thecycle can be replaced with —O—, and C₁₋₆-alkyl and O—C₁₋₆-alkyl can beunsubstituted or substituted with hydroxyl, C₂₋₃₀-alkenyl or aryl, and

X is

wherein E and G are —O— or NR⁶¹, wherein R⁶¹ can be hydrogen orC₁₋₆-alkyl, or R⁶¹ and R⁵³, respectively, R⁵⁶ can, together with thenitrogen, form a five to seven membered cycle, wherein a CH₂ group ofthe cycle can be replaced with —O—, NH, NC(O)C(R⁶²)C═C(R⁶³)R⁶⁴ and/or

R⁵³, R⁵⁶ and R⁶⁰ can be the same or different and are hydrogen,C₁₋₁₀₀-alkyl, C₂₋₃₀-alkenyl, aryl or C(O)R⁶⁵; R⁵⁷, R⁵⁸ and R⁵⁹ can bethe same or different and are hydrogen, C₁₋₁₀₀-alkyl, O—C₁₋₁₀₀-alkyl,aryl or C(O)R⁶⁵; R⁵⁴ and R⁵⁵ can have the same meaning as R⁵⁷ and inaddition can, together with the linking carbon atom, form a five toseven membered cycle, R⁶⁵ has the same meaning as R⁵⁷,C₁₋₁₀₀-alkyl and C₂₋₃₀-alkenyl can be unsubstituted or substituted withone or more aryl, amino, hydroxyl, OC(O)C(R⁷³)═C(R⁷⁴)R⁷⁵,C(O)OC(R⁷⁶)═C(R⁷⁷)R⁷⁸,

wherein R⁶², R⁶³, R⁶⁴, R⁷³, R⁷⁴, R⁷⁵, R⁷⁶, R⁷⁷ and R⁷⁸ can be the sameor different and are hydrogen or C₁₋₆-alkyl,aryl can be unsubstituted or substituted with one or more C₁₋₄-alkyl,andone or more CH₂-groups of C₁₋₁₀₀-alkyl or C₂₋₃₀-alkenyl can be replacedwith —O— and/or —NR⁶¹.

The photoinitiator can also be a titanocene or combinations of abenzophenone, respectively, thioxanthon-derivative with a coinitiator,for example a tertiary amine. But preferably, the photoinitiator is acompound of formula 5.

The composition comprising one or more quaternary ammonium compoundscarrying one or more ethylenically unsaturated groups can also comprisea solvent.

The solvent can be water, an organic solvent or mixtures thereof.

Examples of organic solvents are C₁₋₄-alkanols, C₂₋₄-polyols,C₃₋₆-ketones, C₄₋₆-ethers, C₂₋₃-nitriles, nitromethane,dimethylsulfoxide, dimethylformamide, dimethylacetamide,N-methylpyrolidone and sulfolane, whereby C₁₋₄-alkanols and C₂₋₄-polyolsmay be substituted with C₁₋₄-alkoxy. Examples of C₁₋₄-alkanols aremethanol, ethanol, propanol, isopropanol, butanol, isobutanol,sec-butanol and tert-butanol. Examples of C₁₋₄-alkoxy-derivativesthereof are 2-ethoxyethanol and 1-methoxy-2-propanol. Examples ofC₂₋₄-polyols are glycol and glycerol. Examples of C₃₋₆-ketones areacetone and methyl ethyl ketone. Examples of C₄₋₆-ethers aredimethoxyethane, diisopropylether and tetrahydrofurane. An example of aC₂₋₃-nitrile is acetonitrile. Preferably, the organic solvent isselected from the group consisting of C₁₋₄-alkanols, C₂₋₄-polyols,C₃₋₆-ketones, dimethylformamide and dimethylacetamide, wherebyC₁₋₄-alkanols and C₂₋₄-polyols may be substituted with C₁₋₄-alkoxy. Morepreferably, the organic solvent is a C₁₋₄-alkanol.

Preferably, the solvent is water or a mixture of water and an organicsolvent.

The composition comprising one or more quarternary ammonium compoundscarrying one or more ethylenically unsaturated groups can also compriseadditional components such as biocides, surfactants and de-foamers.

Examples of biocides are 5-chloro-2-(2,4-dichlorophenoxy)phenol, whichis sold, for example, under the tradename Ciba® Irgasan® DP300,N′-tert-butyl-N-cyclopropyl-6-(methylthio)-1,3,5-triazine-2,4-diamine,which is sold under the tradename Ciba® Irgarol® 1051,2-thiazol-4-yl-1H-benzoimidazole, which is sold under the tradenameCiba® Irgaguard® F3000, chlorhexidine, gallic acid, mucobromic acid,itaconic acid and 3-iodo-2-propynyl butyl carbamate, which is sold underthe tradename Maguard™ 1-100.

Examples of surfactants are anionic surfactants such as sodium dodecylsulfate or ammonium lauryl sulfate, cationic surfactants such as cetyltrimethylammonium bromide or cetyl pyridinium chloride, amphotericsurfactants such as dodecyl betaine and nonionic surfactants such ascopolymers of poly(ethylene oxide) and poly(propylene oxide).

Examples of defoamers are mineral oil preparations such as the defoamersold under the tradename Ciba® EFKA® 2526 and polyether functionalizedpolysiloxanes such as the defoamer sold under the tradename Ciba® EFKA®2550

The composition can comprise 0.001 to 100% by weight of one or morequaternary ammonium compounds carrying one or more ethylenicallyunsaturated groups based on the weight of the composition. Preferably,it comprises 0.01 to 80%, more preferably 0.1 to 50%, most preferably,0.1 to 30% by weight of one or more quaternary ammonium compounds.

The composition can comprise 0 to 99% by weight of one or more furtherethylenically unsaturated compounds based on the weight of thecomposition. Preferably, it comprises 0.01 to 80% by weight of one ormore ethylenically unsaturated compounds and more preferably 0.1 to 70%by weight.

The composition can comprise 0 to 50% by weight of one or more radicalinitiators based on the weight of the composition. Preferably, itcomprises 0.01 to 20% by weight of one or more radical initiators andmore preferably 0.1 to 10% by weight.

The composition can comprise 0 to 99.999% by weight of the solvent basedon the weight of the composition. Preferably, it comprises 10 to 99.9%by weight of the solvent and more preferably 20 to 99.5% by weight.

The composition can comprise 0 to 50% by weight of additional componentsbased on the weight of the composition. Preferably, it comprises 0.001to 10% by weight of additional components and more preferably 0.01 to 5%by weight.

The composition comprising one or more quaternary ammonium compoundscarrying one or more ethylenically unsaturated groups can be a solution,an emulsion or a dispersion. Preferably, the composition is a solution.The composition can be applied, for example, using a wire bar or bydipping or spraying.

Curing of the composition can be achieved by polymerization of the oneor more quaternary ammonium compounds carrying one or more ethylenicallyunsaturated groups, and other components, that are capable ofpolymerization and are optionally present in the composition, forexample further ethylenically unsaturated compounds.

If sufficient radicals are present at the oxidized surface of thesubstrate, the quaternary ammonium compounds carrying one or moreethylenically unsaturated groups can polymerize after applicationwithout any further treatment. But, usually, the polymerization isinitiated by treatment with heat, electron-beam or electromagneticradiation. Examples of electromagnetic radiation are X-rays, gamma-rays,ultraviolet radiation, infrared radiation, visible light or microwaves.Preferably, the polymerization is initiated by treatment withelectromagnetic radiation, more preferably by treatment with ultravioletradiation. Usually, the ultraviolet radiation is performed at 60 to 300Watt/cm and a belt speed of 1 to 1000 m/min, preferably 10 to 200 m/min.

Preferably, the polymerization is performed under inert gas atmospherecontaining only traces of oxygen. Examples of inert gas are nitrogen,argon, carbon dioxide and helium. Preferably, the amount of oxygenpresent in the inert gas atmosphere is below 1000 volume ppm, morepreferably, it is below 500 volume ppm, and most preferably, it is below150 volume ppm.

The cured coating layer can have a thickness in the range of from 0.1 to100 μm, preferably from 1 to 50 μm.

In addition, biocides can be applied to the surface of the substrate,for example before the oxidation of the surface (before step (i)), afterthe oxidation of the surface and before applying the composition (afterstep (i) and before step (ii)) after applying the composition and beforecuring (after step (ii) and before step (iii)) or after curing thecomposition (after step (iii)).

The substrate may be also coated with additional coating layers, whichcan be applied to the substrate before or after the coating layer formedby the process of the present invention.

Preferably, the substrate used in the process of the present inventionis already coated with one or more pre-coating layers.

Preferably, the pre-coating layers are formed by a process comprisingthe following steps

(i) oxidizing the surface of the substrate(ii) applying a composition comprising one or more ethylenicallyunsaturated compounds onto the oxidized surface of the substrate and(iii) curing the composition in order to form a pre-coating layer.

The composition used to form the pre-coating layer may also comprise oneor more radical initiators, solvent and additional components.

The composition used to form the pre-coating layer may also comprise oneor more quaternary ammonium compounds carrying one or more ethylenicallyunsaturated groups, although this is not preferred.

The definition of the ethylenically unsaturated compound, the radicalinitiator, the solvent, the additional component and the quaternaryammonium compounds carrying one or more ethylenically unsaturated groupsare the same as above. The oxidation of the surface, the application ofthe composition and the curing of the composition is also the same asdescribed above.

Also part of the present invention is a substrate obtainable by thelatter process.

Also part of the present invention is a mixture of one or morequaternary ammonium compounds carrying one or more ethylenicallyunsaturated groups of formula

whereinR¹, R² and R³ can be the same or different and are hydrogen, halogen orC₁₋₆-alkyl,R⁴, R⁵ and R⁶ can be the same or different and are C₁₋₃₀-alkyl,C₂₋₃₀-alkenyl, C₃₋₈-cycloalkyl, aryl, or R⁴ and R⁵ together with the Nof the ammonium group form a 4 to 8 membered cycle, wherein one CH₂group of the cycle may be replaced with NH or O,Q and Y can be the same or different and are C₁₋₆-alkylene,M is a bridging group,n and m can be the same or different and are 0 or 1,J′ is an anion,wherein C₁₋₃₀-alkyl, C₂₋₃₀-alkenyl, C₃₋₈-cycloalkyl or C₁₋₆-alkylene canbe unsubstituted or substituted with one or more aryl, OC₂₋₃₀-alkenyl,halogen, CN, C(O)OR⁷, C(O)NR⁸R⁹, OR¹⁰, NR¹¹R¹², NHC(O)C(R¹³)═C(R¹⁴)R¹⁵,OC(O)C(R¹⁶)═C(R¹⁷)R¹⁸ or C(O)OC(R¹⁹)═C(R²⁹)R²¹;wherein aryl can be unsubstituted or substituted with one or moreC₁₋₆-alkyl, C₂₋₆-alkenyl, OC₂₋₃₀-alkenyl, halogen, CN, C(O)OR⁷,C(O)NR⁸R⁹, OR¹⁰, NR¹¹R¹², NHC(O)C(R¹³)═C(R¹⁴)R¹⁵, OC(O)C(R¹⁶)═C(R¹⁷)R¹⁸or C(O)OC(R¹⁹)═C(R²⁰)R²¹;wherein R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³, R¹⁴, R¹⁵, R¹⁶, R¹⁷, R¹⁸, R¹⁹,R²⁰ and R²¹ can be the same or different and are hydrogen or C₁₋₆-alkyl,and one or more CH₂-groups of C₁₋₆-alkylene can be replaced byN—CH₂—CH═CH₂, CH—CH═CH₂, NH and/or O,and one or more ethylenically unsaturated compounds of formula

whereinR²², R²³ and R²⁴ can the same or different and can be hydrogen, halogenor C₁₋₆-alkyl,A can be aryl, halogen, CN, C(O)R²⁵, C(O)OR²⁶, OR²⁷, OC(O)R²⁸,NR²⁹C(O)R³⁰ or C(O)NR³¹R³², wherein aryl can be unsubstituted orsubstituted as outlined below,whereinR²⁵, R²⁶, R²⁷, R²⁶, R³¹ and R³² can be the same or different and can behydrogen, C₁₋₁₀₀-alkyl, C₃₋₈-cycloalkyl, C₂₋₃₀-alkenyl, aryl,C₁₋₆-alkylene-aryl-C₁₋₆-alkyl, C₁₋₆-alkylene-aryl-(C₁₋₆-alkyl)₂,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-C₁₋₆-alkyl,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-(C₁₋₅-alkyl)₂ oraryl-C₁₋₃₀-alkylene-aryl, and R²⁹ and R³⁰ can be the same or differentand can have the same meaning as R²⁶, and in addition, together withNC(O) can form a four to seven membered cycle, whereinC₁₋₁₀₀-alkyl, C₁₋₆-alkylene-aryl-C₁₋₆-alkyl,C₁₋₆-alkylene-aryl-(C₁₋₆-alkyl)₂,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-C₁₋₆-alkyl andC₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-(C₁₋₆-alkyl)₂ can be unsubstituted orsubstituted with one or more C₃₋₈-cycloalkyl, aryl, OC₂₋₃₀-alkenyl,halogen, CN, C(O)OR³³, C(O)NR³⁴R³⁵, OR³⁶, NR³⁷R³⁸,NHC(O)C(R³⁹)═C(R⁴⁰)R⁴¹, OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ or C(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷;

C₂₋₃₀-alkenyl group can be unsubstituted or substituted with one or moreC₃₋₈-cycloalkyl, aryl, halogen, CN, C(O)OR³³, C(O)NR³⁴R³⁵, OR³⁶,NR³⁷R³⁸, NHC(O)C(R³⁹)═C(R⁴⁹)R⁴¹, OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ orC(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷,

aryl or aryl-C₁₋₃₀-alkylene-aryl group can be unsubstituted orsubstituted with one or more C₁₋₆-alkyl, C₃₋₈-cycloalkyl, C₂₋₃₀-alkenyl,halogen, CN, C(O)OR³³, C(O)NR³⁴R³⁵, OR³⁶, NR³⁷R³⁸,NHC(O)C(R³⁹)═C(R⁴⁰)R⁴¹, OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ or C(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷,whereinR³³, R³⁴, R³⁵, R³⁶, R³⁷, R³⁸, R³⁹, R⁴⁰, R⁴¹, R⁴², R⁴³, R⁴⁴, R⁴⁵, R⁴⁶ andR⁴⁷ can be the same or different and can be hydrogen or C₁₋₆-alkyl, andwhereinone or more CH₂-groups of C₁₋₁₀₀-alkyl or C₂₋₃₀-alkenyl can be replacedwith —O—, —NH— and/or phenylene, and one CH₂-group of C₃₋₈-cycloalkylcan be replaced with —O—.

The preferences given above for the compounds of formulae 1 and 4 alsoapply to the mixture of these compounds

Also part of the invention is the use of the process of the presentinvention for imparting biocidal activity to the surface of a substrate.

In particular, part of the present invention is the use of the processof the present invention for imparting biocidal activity to the surfaceof substrates used in the medicinal field. Examples of such substratesare substrates which are used in-vivo such as implants, artificialorgans, artificial joints, artificial blood vessels and medicinaldevices such as wound care bandages, catheters, stethoscopes, tubes,syringes and needles.

The advantage of the process of the present invention is that it ispossible to easily coat substrates with biocidal coatings on existingprinting equipment in a large volume continuous process. In addition, ifone or more precoating layers are present, these precoating layers havethe advantage that the efficiency and permeancy of the attachment of thebiocidal coating layer formed by the process of the present inventionbecomes independent from the substrate.

In the biocidel coatings obtained the biocidel agent is covalentlyattached to the substrate and thus cannot leak into the environment.Thus, living organisms, which are not in direct contact to the surfaceof the substrate, are not affected by the biocidal activity of thesurface of the substrate. Besides causing no harm to not targetorganisms, the formation of resistancies towards biocides amongmicroorganisms, for example bacteria, is also not supported.

If the biocidal coating layer is formed from a composition whichcomprises a macromonomer capable of forming a polymer having at leastfive macromonomer units, which macromonomer has a molecular weightranging from 1,000 to 1,000,000,000 g/mol and carries at least twoethylenically unsaturated groups which are (meth)acryloyl moieties or ifthe biocidal coating layer is formed from a composition which comprisesa preferred compound of formula 4, the biocidal coating layer also showsa very high durability, which means that the biocidal activity of thebiocidal coating layer is not significantly affected upon exposure ofthe biocidal layer to various environmental conditions, for example uponprolonged exposure of the biocidal layer to water.

EXAMPLES Example 1 Preparation of Compound 1a

N,N-dimethylaminoethyl methacrylate (28.4 g, 0.18 mol), acetonitrile(210 g) and dodecyl bromide (48.2 g, 0.19 mol) are added into a 1000 mLround bottom flask. The reaction mixture is chilled in an ice water bathand diethyl ether is added until a precipitate is formed. Theprecipitate is filtered and dried to give a white solid (54.5 g, 70.8%yield). ¹HNMR (300 MHz, CDCl₃): 0.87 (t, 3H, alkyl terminal CH₃), 1.24to 1.33 (m, 18H, alkyl CH₂), 1.7 (m, 2H, N—CH₂CH₂), 1.95 (s, 3H, allylicCH₃), 3.49 (s, 6H, N(CH₃)₂), 3.6 (m, 2H, N(CH₂), 4.16 (m, 2H, O—CH₂),4.64 (m, 2H, O—CH₂CH₂), 5.67, (s, 1H, cis vinylic H), 6.14 (s, 1H, transvinylic H).

Example 2 Formation of a Coating Layer Using a First CompositionComprising Compound 1A on the Surface of a Substrate

“AmTopp-C150”, a biaxially orientated polypropylene (BOPP) film suppliedby AmTopp, is subjected on one side to corona pre-treatment using anelectrode having a width of 42 mm and a corona discharge of 680 W at abelt speed of 50 m/min. Then, a 75% by weight solution of a mixture of33/65/2 (weight/weight/weight) 1A/butyl acrylate/Ciba® Irgacure® 2022 inmethanol is applied to one side of the BOPP film using a 40 μm wire bar.The treated BOPP film is stored until the methanol has evaporated. Thedry treated BOPP film is irradiated under nitrogen atmosphere containingabout 500 ppm oxygen using a UV processor with a medium pressure mercurylamp having an output of 120 W/cm at a belt speed of 12 m/min and afocused elliptical reflector.

Ciba® Irgacure® 2022 is a mixture of 17/5/78 (weight/weight/weight) ofCiba® Irgacure® 819, which is sold by Ciba Specialty Chemicals and whichis phenylbis(2,4,6-trimethyl-benzoyl)-phosphine oxide/Lucirin® TPO,which is sold by BASF and which is diphenyl(2,4,6-trimethylbenzoyl)-phosphine oxide)/Ciba® Darocur® 1173, which issold by Ciba Specialty Chemicals and which is2-hydroxy-2-methyl-1-phenylpropan-1-one.

Example 3 Formation of a Coating Layer Using a Second CompositionComprising Compound 1a on the Surface of a Substrate

The process of example 2 is repeated, except that instead of a 75% byweight solution of a mixture of 33/65/2 (weight/weight/weight) 1A/butylacrylate/Ciba® Irgacure® 2022 in methanol, a 75% by weight solution of amixture of 16.4/32.8/1.6/49.2 (weight/weight/weight/weight) 1A/butylacrylate/Ciba® Irgacure® 2022/Sartomer CN2301 in methanol is applied toone side of the BOPP film using a 40 μm wire bar.

Sartomer CN2301 is a branched polyester acrylate oligomer containingmultiple acrylate functionalities and is sold by Sartomer company.

Example 4 Formation of a Coating Layer Using a Second CompositionComprising Compound 1a on the Surface of a Substrate

The process of example 3 is repeated, except that instead of a 40 μmwire bar, a 4 μm wire bar is used.

Comparative Example 1 Formation of a Coating Layer Using the SecondComposition but without Compound 1a on the Surface of a Substrate

The process of example 4 is repeated, except that instead of a 75% byweight solution of a mixture of 16.4/32.8/1.6/49.2(weight/weight/weight/weight) 1A/butyl acrylate/Ciba® Irgacure® 20221Sartomer CN2301 in methanol, a 75% by weight solution of a mixture of49.0/2.0/49.0 (weight/weight/weight) butyl acrylate/Ciba® Irgacure®2022/Sartomer CN2301 in methanol is used.

Comparative Example 2 Formation of a Pre-Coating Layer on the Surface ofa Substrate

The surface of “AmTopp-C150”, a biaxially orientated polypropylene(BOPP) film supplied by AmTopp, is subjected on one side to coronapre-treatment using an electrode having a width of 42 mm and a coronadischarge of 680 W at a belt speed of 50 m/min. Then, 2.2% by weightsolution of a mixture of 31.9/13.7/9.1/22.7/22.7(weight/weight/weight/weight) of

/tripropyleneglycol diacrylate/Ciba® Irgacure® 819, which is sold byCiba Specialty Chemicals and which isphenylbis(2,4,6-trimethylbenzoyl)-phosphine oxide/tricyclodecanedimethanol diacrylate (sold as SR 833S by Sartomercompany)/2-hydroxyethylisocyanurate (sold as SR 368 by Sartomer company)in isopropanol is applied at a rate of 1 g (wet weight)/m² with aflexographic printing station using a 800 LPI 2.2 BCM anilox roll and arubber sleeve at a press speed of 50 m/min. The wet web is dried andcured by UV irradiation using a medium pressure mercury lamp rated for500 W/inch (═Ca. 200 W/cm) and running at 70% output.

Example 5 Formation of a Coating Layer Using the Second CompositionComprising 1A on the Surface of a Substrate, which Already has aPre-Coating Layer

The process of example 3 is repeated, but using the BOPP film obtainedin comparative example 2.

Example 6 Formation of a Coating Layer Using the Second CompositionComprising 1A on the Surface of a Substrate, which Already has aPre-Coating Layer

The process of example 4 is repeated, but using the BOPP film obtainedin comparative example 2.

Comparative Example 3 Formation of a Coating Layer Using the SecondComposition but without 1A on the Surface of a Substrate, which Alreadyhas a Pre-Coating Layer

The process of example 6 is repeated, except that instead of a 75% byweight solution of a mixture of 16.4/32.8/1.6/49.2(weight/weight/weight/weight) 1A/butyl acrylate/Ciba® Irgacure®2022/Sartomer CN2301 in methanol, a 75% by weight solution of a mixtureof 49.0/2.0/49.0 (weight/weight/weight) butyl acrylate/Ciba® Irgacure®2022/Sartomer CN2301 in methanol is used.

Determination of the Bactericidal Activity of the Treated BOPP Films ofExamples 2 to 6

The treated BOPP films obtained in examples 2 to 6 are washed by dippinginto sterile deionized water for 1 minute and then dried under laminarflow. Overnight cultures of bacteria strains (Escherichia coli ATCC10536, respectively, Staphylococcus aureus ATCC 6538) are diluted 1:1000in 0.85% by weight aqueous NaCl solution containing 0.5% by weighttryptic soy broth. Samples (2×2 cm) of the treated BOPP films areinoculated with 0.1 mL bacterial suspension resulting in a finalconcentration of living bacteria of ca. 10⁵ colony forming units (cfu).The samples are incubated at 37° C. for 24 hours. After the incubation,the concentration of living bacteria [cfu] is determined by firsteluting the bacterial cells from the surface of the treated BOPP filmsusing phosphate buffer (0.07 M, pH 7.4) containing 1% by weight Tween 80and 0.3% by weight lecithine as inactivating agents, diluting theeluants in steps 1:10, plating aliquots from each dilution step oncasein soy meal peptone agar, incubating the plates for 24 to 48 hours,counting the number of colonies and recalculating the number of livingbacteria on the surface of the treated BOPP films.

The same procedure is also repeated with untreated BOPP film(comparative example 4) with corona-pretreated BOPP film (comparativeexample 5), and with the treated BOPP films of comparative examples 1 to3. The concentration of living bacteria [cfu] after incubation at 37° C.for 24 hours is determined. The results are outlined in tables 1 and 2below:

TABLE 1 Concentration of living bacteria after 24 hours incubation [cfu]Example No Conditions S. aureus E. coli comp. ex. 4 Untreated BOPP film2.5 × 10⁷ 5.8 × 10⁷ BOPP films with corona pre-treatment comp. ex. 5Only Corona treatment 2.1 × 10⁷ 6.2 × 10⁷ 2 1. composition comprising1A, <100 <100 40 μm 3 2. composition comprising 1A, <100 <100 40 μm 4 2.composition comprising 1A, <100 <100 4 μm Comp. ex. 1 2. composition w/o1A, 4 μm 1.3 × 10⁷ 4.6 × 10⁷

TABLE 2 Concentration of living bacteria after 24 hours incubation [cfu]Example No Conditions S. aureus E. coli BOPP films with pre-coat layerand corona pre-treatment Comp. ex. 2 Only pre-coat and corona 1.7 × 10⁷6.4 × 10⁷ pre-treatment 5 2. composition comprising 1A, <100 Not 40 μmdetermined 6 2. composition comprising 1A, <100 <100 4 μm Comp. ex. 3 2.composition w/o 1A, 4 μm 2.0 × 10⁷ 4.4 × 10⁷

According to Tables 1 and 2 coating layers comprising the quaternaryammonium compound 1A show an excellent bactericidal surface activityagainst S. aureus and E. coli.

Example 7 Preparation of Compound 1B

N-3-chloro-2-hydroxypropyl-N-lauryl-dimethylammonium chloride (10.35 g)and potassium hydroxide (1.71 g) in ethanol (60 g) are added to asolution of polyethyleneimine (molecular weight=800 g/mol, sold asLupasol® FG by BASF) (5 g) and the mixture is heated at 80° C. undernitrogen for 29 hours. Allyl bromide (5.63 g) and potassium hydroxide(2.6 g) are added and the mixture is stirred at reflux for 6 hours. Thereaction mixture is cooled, filtered and concentrated to give an opaquelight yellow syryp. After drying in vacuum over 22 hours, 8.6 g ofcompound 1B are obtained. The polyamine, dodecyl and allyl moieties canbe identified by NMR. Approximately one allyl moiety is present forevery dodecyl moiety and there is about one dodecyl moiety and one allylmoiety for every nine ethyleneamino moieties present.

Example 8 Formation of a Coating Layer Using a Third CompositionComprising 1B on the Surface of a Substrate

A biaxially orientated polypropylene (BOPP) film of 50 μm width suppliedby ExxonMobil Chemical Company is subjected on both sides to coronapre-treatment using one ceramic electrode at a distance of 0.8 mm to theBOPP film and a corona discharge of 1×600 W at a belt speed of 3 m/min.Then, a 1% by weight solution of 90% by weight of the equimolar mixtureof polyethylene glycol (600) diacrylate, sold as SR-610 by SartomerCompany, of formula

and polyethylene glycol (600) di(phenylglyoxylate) of formula

(based an the total weight of 4A, 5A and 1B) and 10% by weight of thequaternary ammonium compound 1B (based on the total weight of 4A, 5A and1B) in isopropanol is applied to both sides of the BOPP film using a 4μm wire bar. The treated BOPP film is stored until the isopropanol hasevaporated. The dry treated BOPP film is irradiated under nitrogenatmosphere containing about 500 ppm oxygen using a UV processor with amedium pressure mercury lamp having an output of 120 W/cm at a beltspeed of 50 m/min and a dichroic reflector. Polyethylene glycol (600)di(phenylglyoxylate) (5A) is prepared as described in example 3 of WO06/067061.

Example 9 Formation of a Coating Layer Using a Third CompositionComprising 1A on the Surface of a Substrate

The process of example 8 is repeated, except that instead of the 10% byweight of 1B (based on the total weight of 4A, 5A and 1B), a 10% byweight of 1A (based on the total weight of 4A, 5A and 1A) in isopropanolis used.

Example 10 Preparation of Compound 1C

Compound 1C is prepared in analogy to example 1, except thatN,N-dimethylaminoethyl acrylate instead of N,N-dimethylaminoethylmethacrylate is used. ¹HNMR (300 MHz, CDCl₃):

0.82 (t, 3H, alkyl terminal CH₃), 1.10 to 1.18 (m, 18H, alkyl CH₂), 1.65(m, 2H, N—CH₂CH₂), 3.45 (s, 6H, N(CH₃)₂), 3.6 (m, 2H, N(CH₂), 4.12 (m,2H, O—CH₂), 4.65 (m, 2H, O—CH₂CH₂), 5.95, (d, 1H, cis vinylic H), 6.08(dd, 1H, trans vinylic H), 6.40 (d, 1H, gem. vinylic H).

1. A process for coating the surface of a substrate, which processcomprises the following steps (i) oxidizing the surface of the substrate(ii) applying a composition comprising one or more quaternary ammoniumcompounds carrying one or more ethylenically unsaturated groups onto theoxidized surface of the substrate and (iii) curing the composition inorder to form a coating layer.
 2. The process of claim 1, wherein theone or more quaternary ammonium compounds carrying one or moreethylenically unsaturated groups are of formula

wherein R¹, R² and R³ can be the same or different and are hydrogen,halogen or C₁₋₆-alkyl, R⁴, R⁵ and R⁶ can be the same or different andare C₁₋₃₀-alkyl, C₂₋₃₀-alkenyl, C₃₋₈-cycloalkyl, aryl, or R⁴ and R⁵together with the N of the ammonium group form a 4 to 8 membered cycle,wherein one CH₂ group of the cycle may be replaced with NH or O, Q and Ycan be the same or different and are C₁₋₁₅-alkylene, M is a bridginggroup, n and m can be the same or different and are 0 or 1, J′ is ananion, wherein C₁₋₃₀-alkyl, C₂₋₃₀-alkenyl, C₃₋₈-cycloalkyl orC₁₋₁₅-alkylene can be unsubstituted or substituted with one or morearyl, OC₂₋₆-alkenyl, halogen, CN, C(O)OR⁷, C(O)NR⁸R⁹, OR¹⁰, NR¹¹R¹²,NHC(O)C(R¹³)═C(R¹⁴)R¹⁵, OC(O)C(R¹⁶)═C(R¹⁷)R¹⁸ or C(O)OC(R¹⁹)═C(R²⁰)R²¹;wherein aryl can be unsubstituted or substituted with one or moreC₁₋₆-alkyl, C₂₋₆-alkenyl, OC₂₋₆-alkenyl, halogen, CN, C(O)OR⁷,C(O)NR⁸R⁹, OR¹⁰, NR¹¹R¹², NHC(O)C(R¹³)═C(R¹⁴)R¹⁵, OC(O)C(R¹⁶)═C(R¹⁷)R¹⁸or C(O)OC(R¹⁹)═C(R²⁰)R²¹; wherein R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³, R¹⁴,R¹⁵, R¹⁶, R¹⁷, R¹⁸, R¹⁹, R²⁰ and R²¹ can be the same or different andare hydrogen or C₁₋₆-alkyl, and one or more CH₂-groups of C₁₋₁₅-alkylenecan be replaced by N—CH₂—CH═CH₂, CH—CH═CH₂, NH and/or O.
 3. The processof claim 1 or 2, wherein the composition also comprises one or morefurther ethylenically unsaturated compounds.
 4. The process of anyclaims 1 to 3, wherein the composition also comprises one or moreradical initiators.
 5. The process of any of claims 1 to 4, wherein thecomposition does not comprise one or more radical initiators.
 6. Theprocess of any of claims 1 to 5, wherein the composition also comprisesa solvent.
 7. The process of any of claims 1 to 6, wherein thecomposition also comprises additional components.
 8. The process of anyof claims 1 to 7, wherein one or more biocides are applied to thesurface of the substrate before step (i), after step (i) and before step(ii), after step (ii) and before step (iii), or after step (iii).
 9. Theprocess of any of claims 1 to 8, wherein the substrate is alreadypre-coated with one or more pre-coating layers.
 10. A substrateobtainable by the process of any of claims 1 to
 9. 11. A mixture of oneor more quaternary ammonium compounds carrying one or more ethylenicallyunsaturated groups of formula

wherein R¹, R² and R³ can be the same or different and are hydrogen,halogen or C₁₋₆-alkyl, R⁴, R⁵ and R⁶ can be the same or different andare C₁₋₃₀-alkyl, C₂₋₃₀-alkenyl, C₃₋₈-cycloalkyl, aryl, or R⁴ and R⁵together with the N of the ammonium group form a 4 to 8 membered cycle,wherein one CH₂ group of the cycle may be replaced with NH or O, Q and Ycan be the same or different and are C₁₋₆-alkylene, M is a bridginggroup, n and m can be the same or different and are 0 or 1, J′ is ananion, wherein C₁₋₃₀-alkyl, C₂₋₃₀-alkenyl, C₃₋₈-cycloalkyl orC₁₋₆-alkylene can be unsubstituted or substituted with one or more aryl,OC₂₋₃₀-alkenyl, halogen, CN, C(O)OR⁷, C(O)NR⁸R⁹, OR¹⁰, NR¹¹R¹²,NHC(O)C(R¹³)═C(R¹⁴)R¹⁵, OC(O)C(R¹⁶)═C(R¹⁷)R¹⁸ or C(O)OC(R¹⁹)═C(R²⁰)R²¹;wherein aryl can be unsubstituted or substituted with one or moreC₁₋₆-alkyl, C₂₋₆-alkenyl, OC₂₋₃₀-alkenyl, halogen, CN, C(O)OR⁷,C(O)NR⁸R⁹, OR¹⁰, NR¹¹R¹², NHC(O)C(R¹³)═C(R¹⁴)R¹⁵, OC(O)C(R¹⁶)═C(R¹⁷)R¹⁸or C(O)OC(R¹⁹)═C(R²⁰)R²¹; wherein R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³, R¹⁴,R¹⁵, R¹⁶, R¹⁷, R¹⁸, R¹⁹, R²⁰ and R²¹ can be the same or different andare hydrogen or C₁₋₆-alkyl, and one or more CH₂-groups of C₁₋₆-alkylenecan be replaced by N—CH₂—CH═CH₂, CH—CH═CH₂, NH and/or O, and one or moreethylenically unsaturated compounds of formula

wherein R²², R²³ and R²⁴ can the same or different and are hydrogen,halogen or C₁₋₆-alkyl, A is aryl, halogen, CN, C(O)R²⁵, C(O)OR²⁶, OR²⁷,OC(O)R²⁸, NR²⁹C(O)R³⁰ or C(O)NR³¹R³², wherein R²⁵, R²⁶, R²⁷, R²⁸, R³¹and R³² can be the same or different and are hydrogen, C₁₋₁₀₀-alkyl,C₃₋₈-cycloalkyl, C₂₋₃₀-alkenyl, aryl, C₁₋₆-alkylene-aryl-C₁₋₆-alkyl,C₁₋₆-alkylene-aryl-(C₁₋₆-alkyl)₂,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-C₁₋₆-alkyl,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-(C₁₋₆-alkyl)₂ oraryl-C₁₋₃₀-alkylene-aryl, and R²⁹ and R³⁰ can be the same or differentand have the same meaning as R²⁶, or, together with NC(O), form a fourto seven membered cycle, wherein C₁₋₁₀₀-alkyl,C₁₋₆-alkylene-aryl-C₁₋₆-alkyl, C₁₋₆-alkylene-aryl-(C₁₋₆-alkyl)₂,C₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-C₁₋₆-alkyl andC₁₋₆-alkylene-C₁₋₁₂-cycloalkyl-(C₁₋₆-alkyl)₂ can be unsubstituted orsubstituted with one or more C₃₋₈-cycloalkyl, aryl, OC₂₋₃₀-alkenyl,halogen, CN, C(O)OR³³, C(O)NR³⁴R³⁵, OR³⁶, NR³⁷R³⁸,NHC(O)C(R³⁹)═C(R⁴⁰)R⁴¹, OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ or C(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷;C₂₋₃₀-alkenyl group can be unsubstituted or substituted with one or moreC₃₋₈-cycloalkyl, aryl, halogen, CN, C(O)OR³³, C(O)NR³⁴R³⁵, OR³⁶,NR³⁷R³⁸, NHC(O)C(R³⁹)═C(R⁴⁰)R⁴¹, OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ orC(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷, aryl or aryl-C₁₋₃₀-alkylene-aryl group can beunsubstituted or substituted with one or more C₁₋₆-alkyl,C₃₋₈-cycloalkyl, C₂₋₃₀-alkenyl, halogen, CN, C(O)OR³³, C(O)NR³⁴R³⁵,OR³⁶, NR³⁷R³⁸, NHC(O)C(R³⁹)═C(R⁴⁰)R⁴¹, OC(O)C(R⁴²)═C(R⁴³)R⁴⁴ orC(O)OC(R⁴⁵)═C(R⁴⁶)R⁴⁷, wherein R³³, R³⁴, R³⁵, R³⁶, R³⁷, R³⁸, R³⁹, R⁴⁰,R⁴¹, R⁴², R⁴³, R⁴⁴, R⁴⁵, R⁴⁶ and R⁴⁷ and can be the same or differentand are hydrogen or C₁₋₆-alkyl, and wherein one or more CH₂-groups ofC₁₋₁₀₀-alkyl or C₂₋₃₀-alkenyl can be replaced with —O—, —NH— and/orphenylene, and one CH₂-group of C₃₋₈-cycloalkyl can be replaced with—O—.
 12. The use of the process of any of claims 1 to 9 for impartingbiocidal activity to the surface of substrates.
 13. The use of claim 12,wherein the substrate is a substrate used in the medicinal field.